Table 3 Literature review on invasive micropapillary carcinoma of the breast
Study | Cases | Age (years)a | ER+ (%) | PR+ (%) | HER2+ (%) | RLN+ (%) | DSS (%) | OS (%) | Follow-up durationa |
|---|---|---|---|---|---|---|---|---|---|
NCDB (current study) | 1818 | 60 | 84.3 | 73.9 | 19.4 | 55.2 | – | 87.5 at 5 years | 4 years |
Kim et al. [2] | 38 | 47.3 | 19.4 | 19.4 | – | 78.9 | – | – | – |
Chen et al. [3] | 624 | 61.7 | 84.8 | 69.9 | – | 52.9 | 92 at 5 years | 84 at 5 years | 33.0 months |
Yu et al. [5] | 267 | 47 | 66.3 | 66.3 | 28.8 | 62.9 | – | 97.7 at 5 years | 59 months |
Chen et al. [6] | 95 | 58.9 | 83.2 | 74.7 | 21.1 | 72.6 | – | 81.9 at 5 years | 60 months |
Shi et al. [7] | 188 | 52.7 | 85.1 | 78.2 | 29.9 | 73.4 | 75.9 at 5 years | – | 40.5 months |
Cui et al. [8] | 25 | 52.3 | 88 | 64 | – | 80 | – | – | 36.5 months |
Walsh & Bleiweiss [37] | 80 | 58.8 | 90.6 | 70.3 | 59.1 | 72.3 | – | – | – |
Vingiani et al. [38] | 49 | 52.7 | 87.8 | 69.4 | 18.4 | 69.4 | – | 89.8 at 6 years | 6 years |
Adrada et al. [39] | 29 | 56a | 82 | 61 | 43 | 62 | – | – | – |
Chen et al. [40] | 100 | 50 | 46 | 27 | – | 84.8 | 63.3 | 59 at 5 years | 60.1 months |
De La Cruz et al. [41] | 16 | 50.9 | 50 | 31.2 | 50 | 92.9 | – | 75 | 38 months |
Luna-Moré et al. [42] | 68 | 54.3 | 74.5 | 46.3 | – | 90.5 | – | 63 | 52.6 months |
Middleton et al. [43] | 14 | 50 | 25 | 12.5 | – | – | 70 at 5 years | – | 57.6 months |
Nassar et al. [44] | 83 | 61 | 71 | – | – | 77 | 40 | 46 | 7 years |
Paterakos et al. [45] | 18 | 55 | 61.1 | < 50 | – | 95.2 | – | 50 at 44 months | 165.6 months |
Pettinato et al. [46] | 62 | 57 | 32 | 20 | 95 | 90 | 49 | – | 5.2 years |
Yamaguchi et al. [47] | 15 | 60.1 | 73 | 67 | 33.3 | 46.6 | – | – | – |
Zekioglu et al. [48] | 53 | 52.5 | 68 | 61 | – | 68.8 | – | 72 | 56.5 months |